Novel therapeutic approaches for gastrointestinal malignancies

This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses...

Full description

Bibliographic Details
Other Authors: Nagaraju, Ganji Purnachandra (Editor), Peela, Sujatha (Editor)
Format: eBook
Language:English
Published: Singapore Springer Nature Singapore 2020, 2020
Edition:1st ed. 2020
Series:Diagnostics and Therapeutic Advances in GI Malignancies
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 03305nmm a2200349 u 4500
001 EB001903737
003 EBX01000000000000001066643
005 00000000000000.0
007 cr|||||||||||||||||||||
008 201103 ||| eng
020 |a 9789811554711 
100 1 |a Nagaraju, Ganji Purnachandra  |e [editor] 
245 0 0 |a Novel therapeutic approaches for gastrointestinal malignancies  |h Elektronische Ressource  |c edited by Ganji Purnachandra Nagaraju, Sujatha Peela 
250 |a 1st ed. 2020 
260 |a Singapore  |b Springer Nature Singapore  |c 2020, 2020 
300 |a XII, 259 p. 53 illus., 39 illus. in color  |b online resource 
505 0 |a Chapter 1. Role of selected transcription factors in pancreatic and colorectal cancer growth and metastasis -- Chapter 2. Adiponectin in gastrointestinal malignancies -- Chapter 3. Small molecule-targeted therapies for GI cancers: success and failures -- Chapter 4. Epigenetic biomarkers for the detection of Gastrointestinal Cancers -- Chapter 5. CD151: A Lateral organizer and modulator of Tumor microenvironment in gastrointestinal cancers -- Chapter 6. Targeting Pathways in GI Malignancies -- Chapter 7. Identification of Potential Key Genes Involved In Progression of Gastric Cancer Using Bioinformatics Analysis -- Chapter 8. Recent Development in the biomarkers for the gastric cancer -- Chapter 9. Gastric Cancer and it’s remedy -- Chapter 10. An intergenic variant rs4779584 between SCG5 and GREM1 contributes to the increased risk of colorectal cancer: A meta-analysis -- Chapter 11. Phytochemicals plus nanomaterial’s on colorectal cancer -- Chapter 12. Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones? -- Chapter 13. Tumor Biomarkers and Diagnosis of Pancreatic Adenocarcinoma -- Chapter 14. Immunotherapy in Gastrointestinal Malignancies -- Chapter 15. The Role of HIF-1α in Hepatocellular Carcinoma 
653 |a Molecular Genetics 
653 |a Radiology 
653 |a Molecular genetics 
653 |a Cancer 
653 |a Nanotechnology 
653 |a Cancer Biology 
700 1 |a Peela, Sujatha  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Diagnostics and Therapeutic Advances in GI Malignancies 
028 5 0 |a 10.1007/978-981-15-5471-1 
856 4 0 |u https://doi.org/10.1007/978-981-15-5471-1?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.994 
082 0 |a 571.978 
520 |a This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies